Louis Moore Bacon's ADPT Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 250.0K shares of Adaptive Biotechnologies Corporation (ADPT) worth $0, representing 0.00% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Louis Moore Bacon has maintained a strategic position in ADPT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2022, adding 121.1K shares. Largest reduction occurred in Q1 2022, reducing 103.2K shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Adaptive Biotechnologies Corporation (ADPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Adaptive Biotechnologies Corporation (ADPT) Trades by Louis Moore Bacon
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2020 | +107,379 | New Buy | 107,379 | $59.13 |
| Q1 2021 | -80,770 | Reduce 75.22% | 26,609 | $40.25 |
| Q2 2021 | +54,401 | Add 204.45% | 81,010 | $40.86 |
| Q3 2021 | +21,312 | Add 26.31% | 102,322 | $33.99 |
| Q4 2021 | +54,289 | Add 53.06% | 156,611 | $28.06 |
| Q1 2022 | -103,242 | Reduce 65.92% | 53,369 | $13.88 |
| Q2 2022 | -28,679 | Reduce 53.74% | 24,690 | $8.10 |
| Q3 2022 | +121,102 | Add 490.49% | 145,792 | $7.12 |
| Q4 2022 | -145,792 | Sold Out | 145,792 | $0.00 |
| Q2 2025 | +250,000 | New Buy | 250,000 | $11.65 |
| Q3 2025 | -250,000 | Sold Out | 250,000 | $0.00 |
Louis Moore Bacon's Adaptive Biotechnologies Corporation Investment FAQs
Louis Moore Bacon first purchased Adaptive Biotechnologies Corporation (ADPT) in Q4 2020, acquiring 107,379 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Adaptive Biotechnologies Corporation (ADPT) for 20 quarters since Q4 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's largest addition to Adaptive Biotechnologies Corporation (ADPT) was in Q2 2025, adding 250,000 shares worth $2.91 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 250,000 shares of Adaptive Biotechnologies Corporation (ADPT), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Adaptive Biotechnologies Corporation (ADPT) represents approximately 0.00% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's peak holding in Adaptive Biotechnologies Corporation (ADPT) was 250,000 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.